Stay updated with breaking news from Biosolution Baltimore. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Canada's health department said on Sunday the 1.5 million doses of the Astrazeneca Plc COVID-19 vaccine imported from Emergent BioSolutions' Baltimore facility were safe and met quality specifications.
Health Canada says the 1.5 million doses of the AstraZeneca Plc COVID-19 vaccine imported from Emergent BioSolutions' Baltimore facility were safe and met quality specifications.
Monday, 26 Apr 2021 08:31 AM MYT A vial and syringe are seen in front of a displayed AstraZeneca logo in this illustration taken January 11, 2021. — Reuters pic Subscribe to our Telegram channel for the latest updates on news you need to know. OTTAWA, April 26 — Canada’s health department said on Sunday the 1.5 million doses of the Astrazeneca Plc Covid-19 vaccine imported from Emergent BioSolutions’ Baltimore facility were safe and met quality specifications. The US Food and Drug Administration (FDA) had stopped AstraZeneca from using the facility earlier this month and halted produc...
Share this article NEW YORK, April 24, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Emergent BioSolutions Inc. (NYSE: EBS) between July 6, 2020 through March 31, 2021, inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 18, 2021. SO WHAT: If you purchased Emergent BioSolutions securities during the Class Period you may be entitled to compensation without paymen...
NEW YORK, April 24, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Emergent BioSolutions Inc. (NYSE: EBS) between July 6, 2020 through March 31, 2021, inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 18, 2021. - Advertisement - SO WHAT:Â If you purchased Emergent BioSolutions securities during the Class Period you may be entitled to compensation without payme...